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We read with interest the letter by Patronoet al regarding our recent article in
Annals of Surgery on viability testing during
hypothermic oxygenated perfusion (HOPE) of
liver grafts.1 The authors of the letter present
their results in 35 machine perfused livers (3
donation after circulatory death (DCD), 32
donation after brain death (DBD)), where they
analyzed perfusate pH, glucose, lactate, and
cytosolic enzymes during dual HOPE before
liver transplantation. They raised some ques-
tions regarding the predictive value of flavin
mononucleotide (FMN) compared with other
classical markers.
Although we agree that the liver enzyme
concentrations obtained from machine perfu-
sates during HOPE or dual HOPE, as well as
during normothermic machine liver perfusion,
often do correlate with serum peak transami-
nases after graft implantation,1,2 we contend
that the prediction of liver function—instead of
injury—is superior for the decision to use or not
high-risk liver grafts.1,2 We have therefore
focused our perfusate analysis on surrogate
markers of liver metabolism during HOPE
treatment, performed on extended human
DCD livers (n ¼ 35/54).1
Within the first 60 minutes of HOPE,
FMN is released from mitochondria, due to an
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the metabolic liver status at start of perfusion.
The detection of flavin in perfusates can there-
fore be considered as a functional marker of the
mitochondrial electron chain, which is in direct
contrast to simple release of cytosolic enzymes
as a consequence of membrane rupture of cells.
In addition, we have observed, that flavin
release correlated with decreased synthesis of
adenosine triphosphate, based on an impaired
mitochondrial complex I–V function.3 Of note,
mitochondrial recovery has been recently iden-
tified as decisive for organ viability.4 Consis-
tently, perfusate FMN is highly predictive for
liver graft function, as shown by correlation of
FMN with International normalized ratio (INR)
and factor V recovery after liver implantation.
This finding appears novel and is in contrast to
the rather weak correlation of conventional
perfusate markers, including liver transami-
nases (Aspartate transaminase (AST), Alanine
transaminase (ALT)), lactate (Supplementary
Table 2),1 and other glycolytic parameters.5,6
We agree, however, that the correlation
of FMN with liver function and graft survival
after implantation requires further validation
in other transplant cohorts, which is currently
performed by several European and American
transplant centers. Of note, perfusate FMN
measurement is a simple and quick technique,
representing a cumulative measurement of the
metabolic status of the whole liver graft, and
can also be determined from stored samples by
fluorimetric assays.
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